BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/16/2021 9:42:17 AM | Browse: 312 | Download: 470
Publication Name World Journal of Virology
Manuscript ID 61435
Country/Territory Italy
Received
2020-12-12 16:10
Peer-Review Started
2020-12-12 16:12
To Make the First Decision
Return for Revision
2021-01-27 07:45
Revised
2021-01-28 19:42
Second Decision
2021-02-24 06:30
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-03-08 19:51
Articles in Press
2021-03-08 19:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-03-13 08:05
Publish the Manuscript Online
2021-03-16 09:17
ISSN 2220-3249 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Infectious Diseases
Manuscript Type Minireviews
Article Title Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID 19 compared with standard of care? A literature review
Manuscript Source Invited Manuscript
All Author List Anna Maria Spera
Funding Agency and Grant Number
Corresponding Author Anna Maria Spera, MD, Doctor, Infectious Diseases, University of Study of Salerno, Largo Ippocrate, Salerno 84131, Italy. annamariaspera@hotmail.it
Key Words COVID 19; SARS-CoV-2; Pandemic; Nucleotide inhibitors; Sofosbuvir; Coronavirus
Core Tip Coronavirus disease 2019 represents a terrible, still unsolved, global problem affecting not only the healthcare system but also the economic and social one. All countries are facing and fighting against this pandemic but there is still no specific treatment for its eradication. Recently some nucleotide inhibitors, already approved and employed for the treatment of hepatitis c virus infection, have been repurposed for treatment of severe acute respiratory syndrome coronavirus 2 infection, because of some common features among coronaviruses and hepatitis c virus. Herein briefly I focused on the effects of this compound on coronavirus disease 2019, based on its pharmacokinetic properties and on results of several completed clinical trials.
Publish Date 2021-03-16 09:17
Citation Spera AM. Are nucleotide inhibitors, already used for treating hepatitis C virus infection, a potential option for the treatment of COVID 19 compared with standard of care? A literature review. World J Virol 2021; 10(2): 53-61
URL https://www.wjgnet.com/2220-3249/full/v10/i2/53.htm
DOI https://dx.doi.org/10.5501/wjv.v10.i2.53
Full Article (PDF) WJV-10-53.pdf
Full Article (Word) WJV-10-53.docx
Manuscript File 61435_Auto_Edited_LM.docx
Answering Reviewers 61435-Answering reviewers.pdf
Audio Core Tip 61435-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 61435-Conflict-of-interest statement.pdf
Copyright License Agreement 61435-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 61435-Language certificate.pdf
Peer-review Report 61435-Peer-review(s).pdf
Scientific Misconduct Check 61435-Bing-Wang JL-1.jpg
Scientific Misconduct Check 61435-Scientific misconduct check.pdf
Scientific Editor Work List 61435-Scientific editor work list.pdf